A new Phase 2 pilot study shows that giving spores of a non-toxic C. difficile bacteria by mouth is effective in stopping repeated bouts of C. diff infection, a major complication of hospitalization.
NEW YORK (MedscapeWire) Mar 12 — Fulminant colitis with Clostridium difficile is becoming more common and more fatal, according to a review of hospitalized patients reported in the March issue of ...
An inflammation of the colon associated with C. difficile — C. difficile colitis — has increased nearly 50 percent from 2001-2005 to 2006-2010, according to a study in the Journal of the American ...
The consumption of dietary supplements and cold therapies containing high concentrations of zinc is now being called into question, following research that suggests it may worsen Clostridium difficile ...
PHILADEPHIA — Both initial and sustained responses to fecal microbiota transplant (FMT) for the treatment of refractory C difficile infection remain high out to 18 months' follow-up, provided patients ...
Dr. Herbert DuPont’s team takes stool from healthy donors, adds salt water, blends the mixture and filters it twice. Smiley N. Pool - Staff Photographer Dr. Herbert DuPont’s team takes stool from ...
The portion of our nervous systems responsible for the 'fight or flight' response can shape the severity of potentially deadly C. difficile infections, according to new research. The portion of our ...
Scientists report that the CRISPR-Cas system can be used to effectively target and eliminate specific gut bacteria, in this case Clostridioides difficile, the pathogen that causes colitis, a chronic, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, announced the presentation of its final 24-week data from the pivotal Phase 3 ...
SAN BRUNO, CA, April 30 – C. diff-associated disease (CDAD), otherwise known as severe intestinal disease brought on by the Clostridium difficile (C. diff) pathogen, has been the subject of heightened ...
Please provide your email address to receive an email when new articles are posted on . Clostridioides difficile infection presents a unique treatment paradox for clinicians: Antibiotics are often ...
New research from the University of Virginia School of Medicine's William A. Petri Jr., MD, PhD, (left) and David Tyus suggests that doctors may be able to save patients from dangerous C. difficile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback